Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Clinical Kidney Journal, 2022Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes
Laursen J., Søndergaard-Heinrich N., Haddock B. et al.
Olink Target 96
Scientific Reports, 2022Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction
Girerd N., Cleland J., Anker S. et al.
Pediatric Research, 2022Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Kindt A., Förster K., Cochius-den Otter S. et al.
Scientific Reports, 2022Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome
Niroomand A., Ghaidan H., Hallgren O. et al.
eBioMedicine, 2022Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet
Dahlin M., Singleton S., David J. et al.
Journal of Nephrology, 2022Assay-related differences in SuPAR levels: implications for measurement and data interpretation
Vasbinder A., Raffield L., Gao Y. et al.
Allergy, 2022T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19
Taeschler P., Adamo S., Deng Y. et al.
Scientific Reports, 2022Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation
Oliveras T., Revuelta-López E., García-García C. et al.
Cancers, 2022Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis
Sánchez-Maldonado J., Collado R., Cabrera-Serrano A. et al.
Frontiers in Immunology, 2022The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Kuijpers Y., Chu X., Jaeger M. et al.
Nature Communications, 2022Genetic analyses identify pleiotropy and causality for blood proteins and highlight Wnt/β-catenin signalling in migraine
Tanha H., Nyholt D., Nyholt D.,
Clinical and Translational Medicine, 2022Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
García‐Hidalgo M., González J., Benítez I. et al.
mBio, 2022Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
Rosendal E., Mihai I., Becker M. et al.
Olink Target 48
Nature Communications, 2022Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability
Kierczak M., Rafati N., Höglund J. et al.
Scandinavian Journal of Pain, 2022Association between systemic inflammation and experimental pain sensitivity in subjects with pain and painless neuropathy after traumatic nerve injuries
Miclescu A., Granlund P., Butler S. et al.
The Journal of Infectious Diseases, 2022Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Kolossváry M., deFilippi C., Lu M. et al.
Journal of Cardiovascular Translational Research, 2022Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Fairhurst-Hunter Z., Walters R., Zink A. et al.
Communications Biology, 2022Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction
Nayar S., Pontarini E., Campos J. et al.
Cell Reports Medicine, 2022TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
van der Ploeg K., Kirosingh A., Mori D. et al.
Proteomes, 2022Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
Mukherjee A., Pednekar C., Kolke S. et al.
4265 publications
Items per page
3361-3380 of 4265 publications